PCSS-B Webinar: Use of Buprenorphine in the Management of Opioid Dependence in Underserved Communities

Prescribers’ Clinical Support System for Opioid Therapies (PCSS-O) is a three year grant funded by Substance Abuse and Mental Health Services Administration (SAMHSA),Center for Substance Abuse Treatment (CSAT). It is a collaborative project led by American Academy of Addiction Psychiatry (AAAP) with: American Dental Association (ADA), American Medical Association (AMA), American Osteopathic Academy of Addiction Medicine (AOAAM), American Psychiatric Association (APA), American Society for Pain Management Nursing (ASPMN), and International Nurses Society on Addictions (IntNSA). These organizations are providing training and education on the safe and effective prescribing of opioid medications in the treatment of pain and/or opioid addiction.
                                   

Webinar Information:

A webinar offered by American Osteopathic Academy of Addiction Medicine(AOAAM). The webinar will give brief introduction to what qualifies as an underserved community.  Will discuss barriers to care that patient’s struggling with addiction may have.  Will discuss risk factors that are common to the overwhelming majority of patient’s with addiction to opiates.  Challenging and rewarding cases will be presented on patients who, with the help of Office Based Opioid Treatment (OBOT), have successfully moved past the cycle and downward spiral of addiction.                                    
                                   

Date: February 27, 2013
Speaker: David Best, DO
Time: 12:00 pm – 1:00 pm ET
                                   

To Register: http://events.constantcontact.com/register/event?llr=c9shxsbab&oeidk=a07e6u9dxbm2b1b768b

Funding for this initiative was made possible (in part) by Prescribers’ Clinical Support System for Opioid Therapies (1H79TI023439) from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.